Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ESGL

ESGL (ESGL) Stock Price, News & Analysis

ESGL logo

About ESGL Stock (NASDAQ:ESGL)

Key Stats

Today's Range
$3.19
▼
$3.29
50-Day Range
$3.01
▼
$4.00
52-Week Range
$1.71
▼
$4.32
Volume
7,667 shs
Average Volume
27,599 shs
Market Capitalization
$25.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

ESGL Holdings Limited provides waste solutions. It regenerates industrial waste into circular products using technologies and renewable energy. The company was founded in 1999 and is based in Singapore.

Receive ESGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ESGL and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ESGL Stock News Headlines

FDA Clears This Under-$5 Biotech for Phase 2 Clinical Trial
A NASDAQ-listed biotech just cleared a major regulatory milestone. The FDA has cleared its lead multiple sclerosis therapy, Lucid-MS, to enter Phase 2 clinical trials - the first time it will be tested in patients with progressive MS. Unlike treatments that suppress the immune system, Lucid-MS is designed to protect myelin, the insulating layer destroyed by the disease. In a pre-clinical mouse model, treatment led to movement recovery including walking. Independent research projects peak annual sales of up to $5 billion if Phase 2 succeeds. The stock still trades under $5 per share.tc pixel
See More Headlines

ESGL Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that ESGL investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), Baidu (BIDU).

Company Calendar

Today
10/06/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Commercial Services & Supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:ESGL
Previous Symbol
NYSEARCA:ESGL
CIK
1957538
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.18
Quick Ratio
0.13

Sales & Book Value

Annual Sales
$5.33 million
Price / Sales
4.79
Cash Flow
$0.26 per share
Price / Cash Flow
12.41
Book Value
$1.83 per share
Price / Book
1.74

Miscellaneous

Outstanding Shares
8,020,000
Free Float
N/A
Market Cap
$25.51 million
Optionable
Not Optionable
Beta
1.48
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NASDAQ:ESGL) was last updated on 10/6/2026 by MarketBeat.com Staff.
From Our Partners